Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of a six‐microRNA signature as a potential diagnostic biomarker in breast cancer tissues
Mojdeh Mahmoudian, Ehsan Razmara, Bashdar Mahmud Hussen, et al.
Journal of Clinical Laboratory Analysis (2021) Vol. 35, Iss. 11
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics
Sara Martino, Chiara Tammaro, Gabriella Misso, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7762-7762
Open Access | Times Cited: 17
Exploring ferroptosis and miRNAs: implications for cancer modulation and therapy
Mobarakeh Ajam-Hosseini, Sadegh Babashah
Molecular and Cellular Biochemistry (2025)
Closed Access
Identification of Biomarkers Associated With CD8+ T Cells in Coronary Artery Disease and Their Pan-Cancer Analysis
Shijian Zhao, Yinteng Wu, Yantao Wei, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Potential diagnostic and prognostic biomarkers for breast cancer: A compiled review
Kareena Moar, Anuja Pant, Vikas Saini, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154893-154893
Closed Access | Times Cited: 7
Cancer Biomarkers in Liquid Biopsy for Early Detection of Breast Cancer: A Systematic Review
Galo Duque, Carlos Manterola, Támara Otzen, et al.
Clinical Medicine Insights Oncology (2022) Vol. 16
Open Access | Times Cited: 9
Identification of miR-125a and miR-106b signature as a potential diagnostic biomarker in breast cancer tissues
Soudeh Ghafouri‐Fard, Bashdar Mahmud Hussen, Solat Eslami
Pathology - Research and Practice (2024) Vol. 256, pp. 155277-155277
Closed Access | Times Cited: 1
Association of microRNA-21 expression with breast cancer subtypes and its potential as an early biomarker
Sau Har Lee, Brianna Brianna
Pathology - Research and Practice (2024) Vol. 254, pp. 155073-155073
Closed Access | Times Cited: 1
Integrated miRNA Signatures: Advancing Breast Cancer Diagnosis and Prognosis
Μαρία Σαμαρά, Eleni Thodou, Marina Patoulioti, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1352-1352
Open Access | Times Cited: 1
Micro-RNAs from Plasma-Derived Small Extracellular Vesicles as Potential Biomarkers for Tic Disorders Diagnosis
Yilong Wang, Xuebin Xu, Haihua Chen, et al.
Brain Sciences (2022) Vol. 12, Iss. 7, pp. 829-829
Open Access | Times Cited: 6
To investigate the internal association between SARS-CoV-2 infections and cancer through bioinformatics
Qinyan shen, Jiang Wang, Liangying zhao
Mathematical Biosciences & Engineering (2022) Vol. 19, Iss. 11, pp. 11172-11194
Open Access | Times Cited: 4
Use of Gain-of-Function Screening to Identify miRNAs Involved in Paclitaxel Resistance in Triple-Negative Breast Cancer
Stéphane Nemours, Carla Solé, Ibai Goicoechea, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13630-13630
Open Access
Peripherical Blood hsa-miR-335-5p Quantification as a Prognostic, but Not Diagnostic, Marker of Gastric Cancer
Lizbeth Ramírez-Vidal, Jared Becerril-Rico, Alberto Monroy-Mora, et al.
Diagnostics (2024) Vol. 14, Iss. 15, pp. 1614-1614
Open Access
Deciphering the prognostic landscape of triple‐negative breast cancer: A focus on immune‐related hub genes and therapeutic implications
HemaNandini Rajendran Krishnamoorthy, K. Ramanathan
Biotechnology and Applied Biochemistry (2024)
Open Access
Serum miR-181a and miR-25 in patients with malignant and benign breast diseases
M. L. Perepechaeva, А. А. Студеникина, A. Yu. Grishanova, et al.
Biomeditsinskaya Khimiya (2023) Vol. 69, Iss. 5, pp. 307-314
Open Access | Times Cited: 1
The role of long non-coding RNAs in the spread of breast cancer
Carol Doss
Authorea (Authorea) (2023)
Open Access | Times Cited: 1
Serum miR-181а and miR-25 Levels in Patients with Breast Cancer or Benign Breast Disease
A. I. Autenshlyus, M. L. Perepechaeva, А. А. Студеникина, et al.
Doklady Biochemistry and Biophysics (2023) Vol. 512, Iss. 1, pp. 279-283
Open Access | Times Cited: 1
Pathway study and systematic evaluation of microRNAs involved in anthracycline- induced cardiotoxicity in breast cancer patients
Xu Xiang
Authorea (Authorea) (2023)
Open Access
Breast cancer invasion by microRNAs aid
A Bedi, A Bedi
Authorea (Authorea) (2023)
Open Access
Biomarkers in breast cancer liquid biopsies: cell-free microRNAs and extracellular vesicles
A. Costa, Alfonso Costa, Duarte Rafael Sampaio Pereira
Authorea (Authorea) (2023)
Open Access
MiRNAs Play a Functional Role in the Development of In Situ Breast Carcinoma
J Wiśniewski, Agnieszka Kozlowski
Authorea (Authorea) (2023)
Open Access
In the age of microRNAs, Triple-Negative Breast Cancer
M Chen
Authorea (Authorea) (2023)
Open Access
Unveiling the Role of MicroRNAs in Breast Cancer Invasion
Krishna Ahluwalia
Authorea (Authorea) (2023)
Open Access
Nutritional Considerations Regarding the Role of MicroRNAs in the Regulation of Obesity-Related Breast Cancer
Michael Rose, Mohammad Ghasan, Emilia Jones
Authorea (Authorea) (2023)
Open Access
Breast cancer lncRNA-microRNA categories: new targets for therapeutic intervention
Lorenzo Bruno, Lorenzo Bruno, Luca Rossi
Authorea (Authorea) (2023)
Open Access
Page 1 - Next Page

Scroll to top